Scott Thomas Jackson

CIK 1566617 · View on SEC EDGAR ↗

Insider

First SEC filing: Nov. 28, 2018 · Latest: Nov. 28, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 33 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 23, 2026 SPRO A 20,000 20,000 Direct Acquired (price as of 2026-08-19)
June 23, 2026 SPRO A 10,000 85,000 Direct +13.33% Acquired (price as of 2026-08-19)
June 12, 2025 SPRO A 20,000 75,000 Direct +36.36% Acquired (price as of 2026-08-19)
May 21, 2025 MGNX A 22,000 22,000 Direct Acquired (price as of 2026-08-19)
May 21, 2025 MGNX A 3,750 3,750 Direct Acquired (price as of 2026-08-19)
May 20, 2025 MGNX M 6,500 0 Direct -100.00% Disposed (price as of 2026-08-19)
May 20, 2025 MGNX M 6,500 11,000 Direct +144.44% Acquired (price as of 2026-08-19)
May 29, 2024 SPRO A 20,000 55,000 Direct +57.14% Acquired (price as of 2026-08-19)
May 21, 2024 MGNX A 16,500 16,500 Direct Acquired (price as of 2026-08-19)
May 21, 2024 MGNX A 6,500 6,500 Direct Acquired (price as of 2026-08-19)
May 20, 2024 MGNX M 4,500 0 Direct -100.00% Disposed (price as of 2026-08-19)
May 20, 2024 MGNX M 4,500 4,500 Direct Acquired (price as of 2026-08-19)
Oct. 5, 2023 SPRO A 20,000 35,000 Direct +133.33% Acquired (price as of 2026-08-19)
May 31, 2023 MGNX A 4,500 4,500 Direct Acquired (price as of 2026-08-19)
May 31, 2023 MGNX A 19,000 19,000 Direct Acquired (price as of 2026-08-19)
May 19, 2023 CBIO A 35,000 35,000 Direct Acquired (price as of 2026-08-19)
Sept. 15, 2022 SPRO A 15,000 15,000 Direct Acquired (price as of 2026-08-19)
May 19, 2022 MGNX A 18,000 18,000 Direct Acquired (price as of 2026-08-19)
May 18, 2022 CBIO A 21,000 21,000 Direct Acquired (price as of 2026-08-19)
Aug. 17, 2021 SPRO A 7,500 7,500 Direct Acquired (price as of 2026-08-19)
May 18, 2021 CBIO A 5,250 5,250 Direct Acquired (price as of 2026-08-19)
May 18, 2021 CBIO A 10,500 10,500 Direct Acquired (price as of 2026-08-19)
May 13, 2021 MGNX A 15,000 15,000 Direct Acquired (price as of 2026-08-19)
Oct. 27, 2020 SPRO A 7,500 7,500 Direct Acquired (price as of 2026-08-19)
June 23, 2020 SPRO A 15,000 15,000 Direct Acquired (price as of 2026-08-19)
May 22, 2020 CBIO A 21,000 21,000 Direct Acquired (price as of 2026-08-19)
May 14, 2020 MGNX A 15,000 15,000 Direct Acquired (price as of 2026-08-19)
May 17, 2019 CBIO A 21,000 21,000 Direct Acquired (price as of 2026-08-19)
May 16, 2019 MGNX A 10,000 10,000 Direct Acquired (price as of 2026-08-19)
Nov. 27, 2018 CBIO A 22,000 22,000 Direct Acquired (price as of 2026-08-19)
May 17, 2018 MGNX A 10,000 10,000 Direct Acquired (price as of 2026-08-19)
May 18, 2017 MGNX A 10,000 10,000 Direct Acquired (price as of 2026-08-19)
Jan. 24, 2017 MGNX A 20,000 20,000 Direct Acquired (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 23, 2026 SPRO Stock Option (right to buy) Common Stock (20,000) $2.15 June 23, 2036 20,000 Acquired
May 21, 2025 MGNX Stock Option (right to buy) Common Stock (22,000) $1.49 May 21, 2035 22,000 Acquired
May 21, 2025 MGNX Restricted Stock Unit Common Stock (3,750) 3,750 Acquired
May 20, 2025 MGNX Restricted Stock Unit Common Stock (6,500) 6,500 Disposed
May 21, 2024 MGNX Stock Option (right to buy) Common Stock (16,500) $4.26 May 21, 2034 16,500 Acquired
May 21, 2024 MGNX Restricted Stock Unit Common Stock (6,500) 6,500 Acquired
May 20, 2024 MGNX Restricted Stock Unit Common Stock (4,500) 4,500 Disposed
May 31, 2023 MGNX Restricted Stock Unit Common Stock (4,500) 4,500 Acquired
May 31, 2023 MGNX Stock Option (right to buy) Common Stock (19,000) $4.67 May 31, 2033 19,000 Acquired
May 19, 2023 CBIO Stock Option (right to buy) Common Stock (35,000) $1.98 May 18, 2033 35,000 Acquired
May 19, 2022 MGNX Stock Option (right to buy) Common Stock (18,000) $3.90 May 19, 2032 18,000 Acquired
May 18, 2022 CBIO Stock Option (right to buy) Common Stock (21,000) $0.60 May 17, 2032 21,000 Acquired
Aug. 17, 2021 SPRO Stock Option (right to buy) Common Stock (7,500) $13.69 Aug. 17, 2031 7,500 Acquired
May 18, 2021 CBIO Stock Option (right to buy) Common Stock (10,500) $2.55 May 17, 2031 10,500 Acquired
May 13, 2021 MGNX Stock Option (right to buy) Common Stock (15,000) $28.88 May 13, 2031 15,000 Acquired
Oct. 27, 2020 SPRO Stock Option (right to buy) Common Stock (7,500) $13.52 Oct. 27, 2030 7,500 Acquired
June 23, 2020 SPRO Stock Option (right to buy) Common Stock (15,000) $13.94 June 23, 2030 15,000 Acquired
May 22, 2020 CBIO Stock Option (right to buy) Common Stock (21,000) $3.00 May 21, 2030 21,000 Acquired
May 14, 2020 MGNX Stock Option (right to buy) Common Stock (15,000) $24.97 May 14, 2030 15,000 Acquired
May 17, 2019 CBIO Stock Option (right to buy) Common Stock (21,000) $12.39 May 16, 2029 21,000 Acquired
May 16, 2019 MGNX Stock Option (right to buy) Common Stock (10,000) $18.00 May 16, 2029 10,000 Acquired
Nov. 27, 2018 CBIO Stock Option (right to buy) Common Stock (22,000) $11.52 Nov. 26, 2028 22,000 Acquired
May 17, 2018 MGNX Stock Option (right to buy) Common Stock (10,000) $21.34 May 17, 2028 10,000 Acquired
May 18, 2017 MGNX Stock Option (right to buy) Common Stock (10,000) $19.57 May 18, 2027 10,000 Acquired
Jan. 24, 2017 MGNX Stock Option (right to buy) Common Stock (20,000) $18.52 Jan. 24, 2027 20,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Nov. 28, 2018 CBIO No securities beneficially owned 0 Direct